Lyell Immunopharma Inc - fluxo de caixa (NASDAQ:LYEL) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -126.25 M-169.56 M-163.69 M-162.39 M-150.02 M -150.02 M Cash from investing activities -121.57 M-11.54 M184.05 M122.42 M54.1 M 54.1 M Cash from financing activities 401.24 M10.63 M1.74 M1.33 M50.41 M 50.41 M Free cash flow -191.75 M-193.83 M-166.38 M-162.86 M-150.8 M -150.8 M

Notícias

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

H.C. Wainwright reitera classificação de compra para ações da Lyell Immunopharma

Citizens reitera classificação das ações da Lyell Immunopharma com base no progresso dos ensaios

Citizens reiterates Lyell Immunopharma stock rating on trial progress

Avago, Lumentum among market cap stock movers on Monday

Lyell Immunopharma conclui tranche de US$ 50 milhões e nomeia novo CFO

Lyell Immunopharma closes $50M equity tranche, names new CFO

Citizens inicia cobertura da Lyell Immunopharma com classificação outperform e preço-alvo de US$ 34

Citizens initiates Lyell Immunopharma stock at outperform, $34 target

Lyell Immunopharma, Inc. (LYEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript